APOB and cancer: Across the quartiles of apoB/apoA-I ratio in Model 1 (adjusted for age, sex, race, PIR, and education level), participants in the highest quartile (Q4) had a 62% greater risk of cancer mortality compared with the first quartile (Q1 = HR: 1.62; 95% CI: 1.38–1.78).